Paula Ollonen1, Johannes Lehtonen, Matti Eskelinen. 1. Department for Social and Health Affairs, State Office in Eastern Finland, P.O. Box 1741, FIN-70101 Kuopio, Finland. paula.ollonen@islh.intermin.fi
Abstract
BACKGROUND: Many case-control studies have investigated the association between anxiety, depression, the history of psychiatric symptoms and risk of breast cancer. However, findings are inconsistent, and results may be explained by the fact that most of the epidemiological data available come from retrospective case-control studies. We have conducted this case-control study with a so-called "limited prospective study design" to reduce the potential for recall bias. MATERIALS AND METHODS: This study is an extension of the Kuopio Breast Cancer Study. Women with breast symptoms were referred by physicians to the Kuopio University Hospital (Finland) and were asked to participate in this study. These subjects were interviewed and all study variables were obtained before any diagnostic procedures were carried out, so neither the investigator nor the subject knew the final diagnosis of breast symptoms at the time of the interview. The research method used was the semistructured in-depth interview method. The Montgomery-Asberg Depression rating scale (MADRS) was used to evaluate the depression of the study subjects. All study subjects were also asked to complete standardised questionnaires (Beck Depression Inventory and Spielberger Trait Inventory). The Forsen Inventory was used to evaluate the history of psychiatric symptoms of the subjects in the six years prior to admission. RESULTS: Clinical examination and biopsy showed breast cancer (BC) in 34 patients, benign breast disease (BBD) in 53 patients, while 28 study subjects were healthy (HSS). The mean "Forsen-score 2-6 yrs" of the BC group was lower (9.8) than the scores of the BBD group (11.8) and the HSS group (12.5) (p = 0.4). The investigator-characterized variables, "MADRS"- and "depression"-variables correlated significantly (p-value under 0.001) with those variables reported by the study subjects, "BDT", "A-trait" and "Forsen-score". The "anxiety"-variables characterized by the investigator correlated to the "A-trait"-variable and "Forsen-score"-variable reported by the study subjects (p-value under 0.05). CONCLUSION: Our results do not support an overall association between anxiety, depression, history of psychiatric symptoms and increased breast cancer risk. However, the exact effects of psychological factors on the various hormones relevant to the development of breast cancer are at present poorly defined.
BACKGROUND: Many case-control studies have investigated the association between anxiety, depression, the history of psychiatric symptoms and risk of breast cancer. However, findings are inconsistent, and results may be explained by the fact that most of the epidemiological data available come from retrospective case-control studies. We have conducted this case-control study with a so-called "limited prospective study design" to reduce the potential for recall bias. MATERIALS AND METHODS: This study is an extension of the Kuopio Breast Cancer Study. Women with breast symptoms were referred by physicians to the Kuopio University Hospital (Finland) and were asked to participate in this study. These subjects were interviewed and all study variables were obtained before any diagnostic procedures were carried out, so neither the investigator nor the subject knew the final diagnosis of breast symptoms at the time of the interview. The research method used was the semistructured in-depth interview method. The Montgomery-Asberg Depression rating scale (MADRS) was used to evaluate the depression of the study subjects. All study subjects were also asked to complete standardised questionnaires (Beck Depression Inventory and Spielberger Trait Inventory). The Forsen Inventory was used to evaluate the history of psychiatric symptoms of the subjects in the six years prior to admission. RESULTS: Clinical examination and biopsy showed breast cancer (BC) in 34 patients, benign breast disease (BBD) in 53 patients, while 28 study subjects were healthy (HSS). The mean "Forsen-score 2-6 yrs" of the BC group was lower (9.8) than the scores of the BBD group (11.8) and the HSS group (12.5) (p = 0.4). The investigator-characterized variables, "MADRS"- and "depression"-variables correlated significantly (p-value under 0.001) with those variables reported by the study subjects, "BDT", "A-trait" and "Forsen-score". The "anxiety"-variables characterized by the investigator correlated to the "A-trait"-variable and "Forsen-score"-variable reported by the study subjects (p-value under 0.05). CONCLUSION: Our results do not support an overall association between anxiety, depression, history of psychiatric symptoms and increased breast cancer risk. However, the exact effects of psychological factors on the various hormones relevant to the development of breast cancer are at present poorly defined.
Authors: Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy Journal: CA Cancer J Clin Date: 2017-04-24 Impact factor: 508.702
Authors: Anna Vespa; Marica Ottaviani; Massimo Rosselli; Simonetta Rossini; Lodovico Balducci Journal: Support Care Cancer Date: 2012-12-21 Impact factor: 3.603